➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Drug Price Trends for ZYPREXA

Email this page to a colleague

« Back to Dashboard

Drug Price Trends for ZYPREXA

Average Pharmacy Cost for ZYPREXA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ZYPREXA 10 MG TABLET 00002-4117-30 21.41196 EACH 2021-01-01
ZYPREXA 15 MG TABLET 00002-4415-30 32.19953 EACH 2021-01-01
ZYPREXA 20 MG TABLET 00002-4420-30 42.90585 EACH 2021-01-01
ZYPREXA 10 MG TABLET 00002-4117-30 20.78972 EACH 2020-09-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for ZYPREXA

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ZYPREXA RELPREVV INTRAMUSCULAR 300MG F/INJ Eli Lilly & Company 00002-7636-11 1 630.57 630.57000 EACH 2020-01-01 - 2023-07-31 Big4
ZYPREXA ZYDIS 5MG TAB Eli Lilly & Company 00002-4453-85 30 448.57 14.95233 EACH 2021-01-01 - 2023-07-31 FSS
ZYPREXA 5MG TAB Eli Lilly & Company 00002-4115-30 30 412.46 13.74867 EACH 2020-01-01 - 2023-07-31 FSS
ZYPREXA ZYDIS 15MG TAB Eli Lilly & Company 00002-4455-85 30 735.10 24.50333 EACH 2021-01-01 - 2023-07-31 Big4
ZYPREXA 10MG TAB Eli Lilly & Company 00002-4117-30 30 457.57 15.25233 EACH 2020-01-01 - 2023-07-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.